Founder — CEO
Valencia Hood-Humphrey, DrPH, MSc, BCPA
This work is not just professional for me. It is personal.
As a child, my symptoms were dismissed. A misdiagnosis led to a life-threatening illness, emergency surgery, and parents being told to call family because the doctors did not expect me to make it.
I made it.
And I have spent many years reflecting on and learning why that moment happened and how it could have been prevented. Now I am making sure it happens to as few people as possible.
I am Dr. Valencia Hood-Humphrey — a Doctor of Public Health (DrPH), Board Certified Patient Advocate (BCPA), and the Founder and CEO of Insightful Doc™ Consulting, LLC. With more than 20 years of experience in life sciences, research, and the biopharmaceutical industry, I founded this practice at the intersection of lived patient experience, doctoral-level public health scholarship, and a methodology that sets this practice apart: implementation science.
Insightful Doc™ Consulting, LLC is the only independent patient advocacy practice bringing implementation science to the advocacy space — systematically closing the gap between what the evidence shows and what patients actually receive. Because evidence that never reaches the patient is evidence that never saved a life.
The Scholarship Behind the Practice
My academic journey reflects a lifelong commitment to evidence, equity, and the science of getting research into the hands of the people who need it most:
- Doctor of Public Health (DrPH) — Capella University, earned with distinction, 4.0 GPA
- Master of Science in Regulatory Affairs for Drugs, Biologics, and Medical Devices — Northeastern University
- Bachelor of Science in Biology (Pre-Medical) — Norfolk State University
- Regulatory Affairs Training Program — Duke University School of Medicine
My doctoral manuscript applied Evidence-Based Practice (EBP) as an intervention to improve organizational strategies for advancing racial and ethnic minority representation in lupus clinical trials — both cutaneous lupus erythematosus (CLE) and systemic lupus erythematosus (SLE). This research sits at the intersection of health equity, implementation science, and the urgent need to ensure that investigational medicines are proven safe and effective for the populations who bear the highest burden of disease.
As an EBP facilitator-practitioner, I aim to work alongside clinicians and industry professionals to translate the best available research evidence into real-world clinical and organizational practice — with a particular focus on underserved and vulnerable populations.
The Advocate Behind the Scholar
My advocacy extends across the full spectrum of patient-centered care. I am a passionate advocate for maternal and infant health equity, with scholarly research examining disparities that persist across the maternal health continuum. As a breastfeeding advocate, I bring not only the evidence and the human dimension to conversations about breastfeeding, but the lived experience as a breastfeeding mother. As a food allergy parent, I bring the lived experience of navigating pediatric food allergies and advocating for improved safety policies and inclusion for impacted students in elementary schools and beyond.
I believe deeply that food is medicine — and that prevention, lifestyle, and non-pharmacological approaches are underutilized, evidence-supported tools for improving population health. This philosophy informs both my advocacy practice and my personal life.
Beyond the Practice
I am a wife, a mother, and an active presence in my community. I maintain an active lifestyle and am committed to modeling the whole-person wellbeing I champion for every client I serve. Foremost in my life is my faith — I am honored to volunteer in my Christian Bible-based field ministry, grounded in Matthew 28:19-20, which reminds me daily that service to others is not a profession. It is a sacred calling.
Every credential earned, every patient guided, every redirect navigated — it all led here. To work that is aligned, intentional, and mine.
Insightful Doc™ Consulting, LLC | 📩 info@insightfuldoc.com
Publications
Publisher: Journal of the American Medical Association, September 28, 2022; Title: Effect of Dimethyl Fumarate vs Interferon β-1a in Patients with Pediatric-Onset Multiple Sclerosis (The CONNECT Randomized Clinical Trial)
The Connect Randomized Clinical Trial
Publisher: International Journal of MS Care, May 2022; Title: Diroximel Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Interim Safety and Efficacy Results from the Phase 3 EVOLVE-MS-1 Study
International Journal of MS Care
Publisher: Fundamentals of International Regulatory Affairs, Fourth Edition/Regulatory Affairs Professional Society, September 2018; Chapter Title: Pharmaceutical Postmarketing Compliance
Fundamentals of International Regulatory Affairs, Fourth Edition
Professional Memberships
National Association of Doctors of Public Health (NADrPH)
Greater National Advocates (GNA)
Alliance of Professional Health Advocates (APHA)
National Association of Healthcare Advocacy (NAHAC)
Continuing Education
2026, APHA, Tips for Preventing Calamity in the Hospital: A Practical Guide for Patient Advocates
2025, National Association of Healthcare Advocacy, The Age-friendly Advantage: Empowering Patients Using the 4Ms Framework
2025, National Academy of Medicine, What Should Kids Eat? Ultra-Processed Foods and Children’s Health